Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
GT802 (Vivacta Biotechnology (Shanghai) Co., Ltd.) in Multiple Sclerosis: NCT07748637 Clinical Landscape Report 2026
16 September 2026
NCT07748637 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07748611 Clinical Landscape Report 2026
16 September 2026
NCT07748611 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
CHM-029 in Acute myeloid leukemia with mutated NPM1: NCT07751991 Clinical Landscape Report 2026
16 September 2026
NCT07751991 clinical landscape for Acute myeloid leukemia with mutated NPM1: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
Belantamab mafodotin in Relapse multiple myeloma: NCT07748689 Clinical Landscape Report 2026
16 September 2026
NCT07748689 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[18F]Florzolotau in Alzheimer Disease: NCT07752784 Clinical Landscape Report 2026](https://synapse-static-patsnap-com.libproxy1.nus.edu.sg/strapi-static/Blog_cover_14_36b6ffee12.jpg)
9 min read
[18F]Florzolotau in Alzheimer Disease: NCT07752784 Clinical Landscape Report 2026
16 September 2026
NCT07752784 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anifrolumab-FNIA in Systemic Lupus Erythematosus: NCT07751848 Clinical Landscape Report 2026
16 September 2026
NCT07751848 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pemetrexed Disodium Hydrate in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07751536 Clinical Landscape Report 2026
16 September 2026
NCT07751536 clinical landscape for Metastatic Malignant Neoplasm to the Leptomeninges: endpoints, sponsor, phase, geography, readouts, asset context and deve…
9 min read
Tirzepatide in Pouchitis: NCT07756359 Clinical Landscape Report 2026
16 September 2026
NCT07756359 clinical landscape for Pouchitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apalutamide in Hormone-dependent prostate cancer: NCT07751133 Clinical Landscape Report 2026
16 September 2026
NCT07751133 clinical landscape for Hormone-dependent prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Nogapendekin alfa inbakicept-pmln in Metastatic Prostate Carcinoma: NCT07756593 Clinical Landscape Report 2026
16 September 2026
NCT07756593 clinical landscape for Metastatic Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Non-Small Cell Lung Cancer: NCT07756645 Clinical Landscape Report 2026
16 September 2026
NCT07756645 clinical landscape for Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Empagliflozin in Alzheimer Disease: NCT07756294 Clinical Landscape Report 2026
16 September 2026
NCT07756294 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.